Mineralys Therapeutics (MLYS) Non Operating Income (2022 - 2026)
Mineralys Therapeutics (MLYS) posted Non Operating Income of $4.97 million for Q2 2026, up 43.1% from $3.47 million a year earlier but down 17.2% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Non Operating Income (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Mineralys Therapeutics was $21.22 million, up 72.6% year-over-year; for FY2025, it was $15.95 million, up 9.3% from FY2024.
- Annual Non Operating Income has increased for three consecutive years, with a three-year compound annual growth rate of 111.8% (FY2022 to FY2025).
- In prior years, Mineralys Therapeutics' Non Operating Income was $14.59 million in FY2024 (+14.4%), $12.76 million in FY2023 (+659.5%) and $1.68 million in FY2022.
- Quarterly Non Operating Income has run from a low of $745,000 in Q3 2022 to a high of $6.05 million in Q4 2025 over five years.
- On a year-over-year basis, Non Operating Income has increased in each of the last four quarters, with growth averaging 33.9% over the last eight quarters.
- The strongest year-over-year quarter for Non Operating Income in the past five years was Q3 2023, with growth of 371.5%; the weakest was Q1 2025, with a decline of 42.0%.
- According to Business Quant data, Non Operating Income for the three prior quarters was $6 million (Q1 2026), $6.05 million (Q4 2025) and $4.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Mineralys Therapeutics | 2.22 Bn | 2.22 Bn | - | 4.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.97 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Sep 30, 2025 | 4.20 Mn |
| Jun 30, 2025 | 3.47 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 3.76 Mn |
| Jun 30, 2024 | 4.15 Mn |
| Mar 31, 2024 | 3.85 Mn |
| Dec 31, 2023 | 3.32 Mn |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 3.59 Mn |
| Mar 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 935,000.00 |
| Sep 30, 2022 | 745,000.00 |
API Access
Mineralys Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();